Effect of electroacupuncture for pain relief in diabetic distal symmetric polyneuropathy: a pilot randomized clinical trial.

Diabetic nerve pain, medically known as distal symmetric polyneuropathy (DSPN), is a common and painful complication of type 2 diabetes that significantly impacts quality of life. Standard pain medications often provide inadequate relief and can cause unwanted side effects, leading researchers to explore alternative treatments. This study investigated whether electroacupuncture—a technique that combines traditional acupuncture needles with mild electrical stimulation—could help reduce nerve pain in diabetic patients.

Researchers in Mexico City conducted a small clinical trial with 18 patients who had confirmed diabetic nerve damage. Participants received either real electroacupuncture or sham (fake) electroacupuncture twice weekly for eight weeks, totaling 16 sessions of 20 minutes each. Neither patients nor evaluators knew who received which treatment, ensuring unbiased results.

The findings were encouraging for those receiving real electroacupuncture. Patients reported significant reductions in pain intensity: current pain decreased by 58%, least pain by 40%, worst pain by 19%, and average pain by 63% compared to their starting levels. Those receiving sham treatment showed no meaningful changes. Importantly, no adverse effects were reported during the study.

While these results are promising, it's important to understand this was a small pilot study designed to test feasibility. The researchers emphasize that larger studies are needed to confirm these findings before electroacupuncture can be widely recommended for diabetic nerve pain. However, for patients struggling with painful diabetic neuropathy who haven't found adequate relief from conventional treatments, electroacupuncture may be worth discussing with their healthcare team as a potentially safe complementary option. If considering acupuncture, seek a licensed and qualified practitioner experienced in treating neuropathic pain conditions.

This pilot double-blind, sham-controlled RCT evaluated electroacupuncture (EA) efficacy for painful axonal DSPN in 18 type 2 diabetes patients in Mexico City. Participants received true EA or sham EA twice weekly for eight weeks (16 sessions, 20 minutes each). Primary outcomes included DN-4 and Numeric Rating Scale (NRS) scores at baseline and post-intervention.

Results showed no significant DN-4 changes in either group. However, the EA group demonstrated statistically significant NRS reductions: current pain intensity decreased 2.78 points (58% reduction, p=0.028), least pain by 2.11 points (40%, p=0.028), worst pain by 4 points (19%, p=0.050), and average pain by 3.67 points (63%, p<0.001). Sham EA showed no significant changes. No adverse events were reported.

Clinical implications: EA may provide clinically meaningful pain reduction in painful DSPN with favorable safety profile. However, small sample size (n=18) limits generalizability. These hypothesis-generating findings warrant larger multicentre trials to confirm efficacy and elucidate mechanisms before definitive clinical recommendations.